Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Genetic Technologies ( (AU:GTG) ) has issued an update.
Genetic Technologies has announced the resignation of director Anthony Hartman, effective 9 September 2025, and the appointment of experienced ASX-listed company director Steve Nicols as a non-executive director from 19 December 2025, bolstering the board’s corporate and insolvency expertise as it advances recapitalisation and relisting plans. The company also acknowledged previous non-compliance with ASX disclosure rules related to Hartman’s resignation and interests notice, and has introduced enhanced governance measures, including formal director appointment and resignation checklists and stricter notification procedures, which the board believes will ensure future compliance as it navigates acquisitions, recapitalisation, and its return to the market.
More about Genetic Technologies
Genetic Technologies Limited is an ASX-listed company undergoing recapitalisation and working toward relisting on the Australian Securities Exchange, with a strategic focus on restructuring its operations and completing proposed acquisitions to support its next phase of development.
Technical Sentiment Signal: Sell
Current Market Cap: A$5.67M
For an in-depth examination of GTG stock, go to TipRanks’ Overview page.